logo
Book a meeting
FutraMed

Futra Med

Medical Devices, 9690 S 300 W, Sandy, Utah, 84070, United States, 1-10 Employees

futramed.com

  • LinkedIn

Who is FUTRAMED

FutraMed Inc. was founded in the State of Utah in 2011 for the purpose of engaging in the creation and application of technology to provide solutions for individuals with substance abuse ...

Read More

lock icon Get Full Access
map
  • 9690 S 300 W, Sandy, Utah, 84070, United States Headquarters: 9690 S 300 W, Sandy, Utah, 84070, United States
  • 2011 Date Founded: 2011
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Medical Devices

SIC SIC Code: 2834

checked-icon Does something look wrong? Fix it. | View contact records from FUTRAMED

FutraMed Org Chart and Mapping

Employees
Douglas Harding

Douglas Harding

Founder

See Full Org Chart arrow
email-formate-icon
View Email Formats for FutraMed
arrow
signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

Join Now

crown-icon Free credits every month

Frequently Asked Questions Regarding FutraMed

Answer: FutraMed's headquarters are located at 9690 S 300 W, Sandy, Utah, 84070, United States

Answer: FutraMed's official website is https://futramed.com

Answer: FutraMed's revenue is $1 Million to $5 Million

Answer: FutraMed's SIC: 2834

Answer: FutraMed has 1-10 employees

Answer: FutraMed is in Medical Devices

Answer: FutraMed contact info: Phone number: Website: https://futramed.com

Answer: FutraMed Inc. was founded in the State of Utah in 2011 for the purpose of engaging in the creation and application of technology to provide solutions for individuals with substance abuse and other physical and behavioral limitations. With the consumption of painkillers soaring throughout the world, FutraMed has developed a patented medical device that is a hand-held, portable, battery-powered, cranial stimulator called the Limoge TCES. It is used to stabilize, reduce or replace dosages of opioids prescribed in the treatment of pain conditions, both acute and chronic. A fully functional, IEC compliant, manufacturer-ready device has been created and we are now working with regulatoy agencies to allow the device to be available for the public. The technology for the device, a transcutaneous electrical cranial stimulator, is based on the work of Dr. Aime Limoge of Paris France and the Limoge Current which he developed. Numerous studies have been performed using the Limoge Current showing that it enhances the treatment for pain and reduces the need for opioids. In collaboration with Dr. Limoge and his associates, our team was able to effectively replicate the Limoge Current and create a device that is simple to use, low cost, battery powered, meets regulatory requirements, and is easy to manufacture.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access